TY - JOUR
KW - Causal analysis
KW - Effectiveness
KW - Older Adults
KW - SGLT2 inhibitors
KW - Safety
AU - L. Güdemann
AU - K. Young
AU - N. Thomas
AU - R. Hopkins
AU - R. Challen
AU - A. Jones
AU - A. Hattersley
AU - E. Pearson
AU - B. Shields
AU - J. Bowden
AU - J. Dennis
AU - A. McGovern
AD - Institute of Biomedical & Clinical Science, University of Exeter Medical School, Exeter, UK. l.guedemann@exeter.ac.uk.
Institute of Biomedical & Clinical Science, University of Exeter Medical School, Exeter, UK.
Division of Molecular & Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
AN - 38836934
BT - Diabetologia
DO - 10.1007/s00125-024-06190-9
DP - NLM
ET - 2024/06/05
LA - eng
N1 - 1432-0428
Güdemann, Laura M
Orcid: 0000-0001-6933-3653
Young, Katie G
Orcid: 0000-0002-1014-9058
Thomas, Nicholas J M
Orcid: 0000-0003-2513-7022
Hopkins, Rhian
Orcid: 0000-0001-6054-3582
Challen, Robert
Jones, Angus G
Orcid: 0000-0002-0883-7599
Hattersley, Andrew T
Orcid: 0000-0001-5620-473x
Pearson, Ewan R
Orcid: 0000-0001-9237-8585
Shields, Beverley M
Orcid: 0000-0003-3785-327x
Bowden, Jack
Orcid: 0000-0003-2628-3304
Dennis, John M
Orcid: 0000-0002-7171-732x
McGovern, Andrew P
Orcid: 0000-0002-6833-9399
MASTERMIND consortium
MR/N00633X/1/MRC_/Medical Research Council/United Kingdom
Journal Article
Germany
Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190-9.
PY - 2024
SN - 0012-186x
T2 - Diabetologia
TI - Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach
ER -